Top 10 Reasons to Eat Your Cruciferous Veggies

10 Reasons to Eat Your Cruciferous Vegetables

Top 10 Reasons to Eat Your Cruciferous Veggies

Everyone knows that eating vegetables has profound health benefits. But, like all foods, not all vegetables are created the same. Some are better than others in terms of nutritional content, and overall contribution to vibrant health. If you look more closely at their phytochemical [plant-based chemical] content, or the growing amount of research into their specific effects on the body and disease, a few vegetables appear to be downright “miracle” foods!

One such group of veggies are those of the Brassica family; commonly known as cruciferous. These include broccoli, brussel sprouts, cabbage, cauliflower, kale, radish, rutabaga, turnip and even arugula.

What makes this group of veggies so special? Sulforaphane.

Sulforaphane is a phytochemical abundant in cruciferous vegetables, and it’s been getting a ton of attention from researchers. But it all starts with glucoraphanin.

Sulforaphane is produced when the enzyme myrosinase converts glucoraphanin, a glucosinolate (natural compound found in some plants), through a chemical reaction induced by damage to the plant, such as cutting or chewing. As such, glucoraphanin is known as the precursor to sulforaphane.

(more…)

The Role of Selenium in Cellular Health and Cancer Prevention


By Dr. Mercola

Micronutrients are incredibly important and vital to your health, but are you getting enough, and perhaps even more importantly, the right form? Mark Whitacre, Ph.D., is a leading expert on one of the most important micronutrients, selenium.

Selenium is a trace element a Swedish chemist, Baron Jöns Jacob Berzelius, discovered almost 200 years ago. Today, modern scientists recognize it as an essential mineral for human health, with potent anti-inflammatory, antiviral and anti-cancer activity.

There are fewer than 100 selenium Ph.D. biochemists in the world. Whitacre received his master’s degree in nutrition at Ohio State University in Columbus, Ohio, in the late 1970s — a time when selenium was quickly becoming a hot topic.

“After I finished my master’s degree at Ohio State, I went to Cornell University to get my Ph.D. in nutritional biochemistry and to study under Gerald F. Combs Jr.[,Ph.D., who] was probably the leading authority in selenium research, and probably still is,” Whitacre says.

During his Ph.D. research at Cornell in selenium biochemistry, Whitacre researched the biochemical role of selenium in pancreatic cells. At the time, researchers were just starting to discover the biological necessities for selenium.

Selenium in Health and Disease Prevention

(more…)

Morphine & Cancer – Yet Another Dr F&(% Up

If you’ve listened to me for any length of time you know I consistently beat the drum that if you poison people you should only ever expect one result and that is to see a decline in health.  It doesn’t matter if a “Nice Dr” (what our society calls “good”) recommends the poison or whether or not it comes from a “Specialist” it is still poison.

Morphine is no exception to this rule and it comes with a big price.  Many people with Cancer end up finding themselves in a great deal of pain and it is not uncommon for a Dr to prescribe them Morphine, which results in more Cancer.  Dr’s making problems worse should come as no surprise in 2016, but sadly it still surprises many.

In fact, The Nutrition Institute of America funded an independent review of “government-approved” medicine that was published in 2006. Professors Gary Null and Dorothy Smith, along with doctors Carolyn Dean, Martin Feldman and Debora Rasio titled the report “Death by Medicine.”

The Conclusion?  Iatrogenic death rate in the US (death caused by doctors and/or medical treatments) is 783,936 a year. Over a decade, the scientists predict that iatrogenic deaths will total about 7.8 million and this is with a 5-20% reporting rate due to lawsuit fears meaning that the number could be 20X higher. (more…)

Why a Cancer-Free Diagnosis May Not Mean Cancer is Gone

Image result for cancer free

(The Best Years in Life) Being told you’re cancer-free by your doctor is certainly a reason for celebration. However, rather than declaring victory over cancer, such news should be viewed with cautious optimism. Unfortunately, a mainstream prognosis of being cancer-free often does not mean that the cancer is completely gone. Regardless of whether the cancer is actually gone or not, mainstream cancer treatments often ensure that cancer will return and may be harder to beat than ever.

Conventional treatments often create dangerous cancer stem cells and often only eliminate the weakest cancer cells – leaving behind more potent cancer cells to multiply and roar back with a vengeance. In addition, conventional cancer treatments fail to address and eliminate the root causes that enabled cancer to gain a foothold in the first place. Further, the two main forms of mainstream cancer treatments – chemotherapy and radiation – usually severely impair our immune systems, which are our vital natural first lines of defense for beating and avoiding cancer.

“Not Detectable” Does Not Mean Cancer-Free

(more…)

New Study Finds Chemo Kills 50% of Patients In First 30 Days

Photo by Dreaming in the deep south

The medical community has long touted chemotherapy as the only viable treatment for cancer, but a new study is showing that chemo, as has long been suspected, is actually itself, a killer. A new study in England shows that 50% of all cancer patients who receive chemotherapy treatments die within 30 days from the treatment, not the cancer.  One in five breast cancer patients receiving palliative care at Cambridge University Hospitals died from treatment.

Per the study’s conclusions:

Between Jan 1, and Dec, 31, 2014, we included 23 228 patients with breast cancer and 9634 patients with non-small cell lung cancer (NSCLC) in our regression and trust-level analyses. 30-day mortality increased with age for both patients with breast cancer and patients with NSCLC treated with curative intent, and decreased with age for patients receiving palliative SACT

Our findings show that several factors affect the risk of early mortality of breast and lung cancer patients in England and that some groups are at a substantially increased risk of 30-day mortality. The identification of hospitals with significantly higher 30-day mortality rates should promote review of clinical decision making in these hospitals. Furthermore, our results highlight the importance of collecting routine data beyond clinical trials to better understand the factors placing patients at higher risk of 30-day mortality, and ultimately improve clinical decision making. Our insights into the factors affecting risk of 30-day mortality will help treating clinicians and their patients predict the balance of harms and benefits associated with SACT.

(more…)